Advertisement

Effect of antispastic agents (calcium antagonists and/or isosorbide dinitrate) on high-sensitivity C-reactive protein in patients with coronary vasospastic angina pectoris and no hemodynamically significant coronary artery disease

      Levels of high-sensitivity C-reactive protein were measured before and after 3 months of treatment with antispastic agents (calcium antagonists and/or isosorbide dinitrate) in 27 patients who had coronary vasospastic angina pectoris and no hemodynamically significant coronary artery disease. Levels of high-sensitivity C-reactive protein decreased after treatment with antispastic agents.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Hung M.J.
        • Cherng W.J.
        Comparison of white blood cell counts in acute myocardial infarction patients with significant versus insignificant coronary artery disease.
        Am J Cardiol. 2003; 91: 1339-1342
        • Hung M.J.
        • Kuo L.T.
        • Cheng C.W.
        • Chang C.P.
        • Cherng W.J.
        Comparison of peripheral monocyte counts in patients with and without coronary spasm and without fixed coronary narrowing.
        Am J Cardiol. 2004; 93: 620-624
        • Berk B.C.
        • Weintraub W.S.
        • Alexander R.W.
        Elevation of C-reactive protein in “active” coronary artery disease.
        Am J Cardiol. 1990; 65: 168-172
        • Pasceri V.
        • Willerson J.T.
        • Yeh E.T.H.
        Direct proinflammatory effect of C-reactive on human endothelial cells.
        Circulation. 2000; 102: 2165-2168
        • Zwaka T.P.
        • Hombach V.
        • Torzewski J.
        C-reactive protein-mediated low density lipoprotein uptake by macrophages.
        Circulation. 2001; 103: 1194-1197
        • Ishikawa T.
        • Hatakeyama K.
        • Imamura T.
        • Date H.
        • Shibata Y.
        • Hikichi Y.
        • Asada Y.
        • Eto T.
        Involvement of C-reactive protein obtained by directional coronary atherectomy in plaque instability and developing restenosis in patients with stable or unstable angina pectoris.
        Am J Cardiol. 2003; 91: 287-292
        • Ishikawa T.
        • Imamura T.
        • Hatakeyama K.
        • Date H.
        • Nagoshi T.
        • Kawamoto R.
        • Matsuyama A.
        • Asada Y.
        • Eto T.
        Possible contribution of C-reactive protein within coronary plaque to increasing its own plasma levels across coronary circulation.
        Am J Cardiol. 2004; 93: 611-614